ZBTB7B and hepatocellular carcinoma: Zbtb7b is compensatively increased during progression of MASLD and restricts lipid deposition in the liver by regulating H19‐mediated de novo lipogenesis and fatty acid oxidation, which protects against MASLD‐related HCC initiation.